Association studies of Toll-like receptor gene polymorphisms with allograft survival in renal transplant recipients of North India.

Priyanka Srivastava , Anugya Singh , Praveen Kesarwani , Praveen K. Jaiswal
Clinical Transplantation 26 ( 4) 581 -588

6
2012
Anti-tumor response in T cells with CD8 independent high affinity TCR remains unaffected with aging (VAC11P.1009)

Pravin Kesarwani , Shikhar Mehrotra , Andrijauskaite Kristina , Mark Rubinstein
Journal of Immunology 192

2014
Reduced ectonucleotidase expression on TGF-β independent Th17 improves tumor control (VAC11P.1006)

Myroslawa Soloshchenko , Chrystal Paulos , Pravin Kesarwani , Christine Webster
Journal of Immunology 192

2014
Lack of p53 augments anti-tumor functions of cytolytic T cells (VAC11P.1005)

Pravin Kesarwani , Krishnamurthy Thyagarajan , Shikhar Mehrotra , Anirban Banerjee
Journal of Immunology 192

2014
GSTM1, GSTM3 and GSTT1 Gene Variants and Risk of Benign Prostate Hyperplasia in North India

Rama Devi Mittal , Pravin Kesarwani , Ranjana Singh , Dinesh Ahirwar
Disease Markers 26 ( 2) 85 -91

12
2009
Rescuing CTLs from undergoing TCR restimulation induced necroptosis improves tumor control (VAC7P.1034)

Pravin Kesarwani , Gina Scurti , Radhika Gudi , Shilpak Chatterjee
Journal of Immunology 194

2015
Increased expression of anti-oxidant molecule Thioredoxin-1 on T cells improves immunotherapeutic control of tumors (VAC7P.1039)

Nilanjana Maulik , Myroslawa Soloshchenko , Pravin Kesarwani , Shilpak Chatterjee
Journal of Immunology 194

2015
Increasing Th1 phenotype in Th17 cells improves anti-tumor T cells function (VAC7P.1032)

Myroslawa Soloshchenko , Chrystal Paulos , Pravin Kesarwani , Jianing Fu
Journal of Immunology 194

2015
Perhexiline Demonstrates FYN-mediated Antitumor Activity in Glioblastoma.

Shiva Kant , Pravin Kesarwani , Anthony R. Guastella , Praveen Kumar
Molecular Cancer Therapeutics 19 ( 7) 1415 -1422

2
2020
Association between -174 G/C promoter polymorphism of the interleukin-6 gene and progression of prostate cancer in North Indian population.

Pravin Kesarwani , Dinesh Kumar Ahirwar , Anil Mandhani , Rama Devi Mittal
DNA and Cell Biology 27 ( 9) 505 -510

28
2008
XRCC1 codon 399 mutant allele: a risk factor for recurrence of urothelial bladder carcinoma in patients on BCG immunotherapy.

Rama Devi Mittal , Ranjana Singh , Parmeet Kaur Manchanda , Dinesh Ahirwar
Cancer Biology & Therapy 7 ( 5) 645 -650

32
2008
Thioredoxin-1 improves the immunometabolic phenotype of antitumor T cells

Paramita Chakraborty , Shilpak Chatterjee , Pravin Kesarwani , Krishnamurthy Thyagarajan
Journal of Biological Chemistry 294 ( 23) 9198 -9212

8
2019
Anti-oxidant capacity and anti-tumor T cell function: A direct correlation

Pravin Kesarwani , Krishnamurthy Thyagarajan , Shilpak Chatterjee , Viswanathan Palanisamy
OncoImmunology 4 ( 1) e985942

4
2015
Influence of genetic polymorphisms in GSTM1, GSTM3, GSTT1 and GSTP1 on allograft outcome in renal transplant recipients.

Ranjana Singh , Parmeet K. Manchanda , Pravin Kesarwani , Aneesh Srivastava
Clinical Transplantation 23 ( 4) 490 -498

14
2009
Association of GSTM3 intron 6 variant with cigarette smoking, tobacco chewing and alcohol as modifier factors for prostate cancer risk

Pravin Kesarwani , Ranjana Singh , Rama Devi Mittal
Archives of Toxicology 83 ( 4) 351 -356

23
2009
Redox regulation of T-cell function: from molecular mechanisms to significance in human health and disease.

Pravin Kesarwani , Anuradha K. Murali , Amir A. Al-Khami , Shikhar Mehrotra
Antioxidants & Redox Signaling 18 ( 12) 1497 -1534

199
2013
Blocking TCR restimulation induced necroptosis in adoptively transferred T cells improves tumor control.

Pravin Kesarwani , Paramita Chakraborty , Radhika Gudi , Shilpak Chatterjee
Oncotarget 7 ( 43) 69371 -69383

6
2016
CBMT-27. ABERRANT AMINO ACID METABOLISM EXPOSE NOVEL FUNCTIONAL VULNERABILITIES IN GLIOBLASTOMA

Antony Prabhu , Anthony Guastella , Shiva Kant , Pravin Kesarwani
Neuro-oncology 21

2019
2019
IMMU-19. QUINOLINATE-INDUCED IMMUNE SUPPRESSION IN GLIOBLASTOMA

Pravin Kesarwani , Shiva Kant , Antony Prabhu , Prakash Chinnaiyan
Neuro-oncology 21

2019